Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer



Status:Withdrawn
Conditions:Lung Cancer, Prostate Cancer, Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:2/16/2018
Start Date:March 2007
End Date:July 2018

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Optical Coherence Tomography for Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer

This study has been designed to utilize already obtained biopsy specimens for investigation
of the utility of a new, non-invasive optical diagnostic technique. The study will allow a
careful correlation between the Optical coherence tomography findings and conventional
histology.

Optical coherence tomography is a non-invasive diagnostic technique that can provide
information about tissue abnormalities, change in structure of an organ. This technique uses
a near-infrared diode to emit light that can produce images of the specimen under
investigation without causing damage or alterations.

Inclusion Criteria:

- Adult 18 years and older

- Having procedure of endobronchial, transbronchial, and / or pleural biopsy

Exclusion Criteria:

- Currently participating in any other investigational drug or device evaluation.

- Currently taking drugs that are sensitive to light.
We found this trial at
2
sites
Pulmonary and Critical Care Medicine, UCI Medical Center
Orange, California 92868
Principal Investigator: Matthew Brenner, M.D.
Phone: 714-456-5150
?
mi
from
Orange, CA
Click here to add this to my saved trials
Urology department, UCI Medical Center
Orange, California 92868
Principal Investigator: Matthew Brenner, M.D
?
mi
from
Orange, CA
Click here to add this to my saved trials